Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Allison

Showing results (521-530 of 647) with videos related to

Pageof 65
Sort By:
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|July 10, 2009
Readiness to change as a mediator of the effect of a brief motivational intervention on posttreatment alcohol-related consequences of injured emergency department hazardous drinkersL A R Stein, P Allison Minugh, Richard Longabaugh, et al.
Immunity|March 31, 2019
Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell StatesSpencer C Wei, Roshan Sharma, Nana-Ama A S Anang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cellsJun Sik Lee, Lisa Scandiuzzi, Anjana Ray, et al.
Alcoholism, Clinical and Experimental Research|October 27, 2007
Treatment completion in a brief motivational intervention in the emergency department: the effect of multiple interventions and therapists' behaviorJanette Baird, Richard Longabaugh, Christina S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicitiesSalahaldin A Tahir, Jianjun Gao, Yuji Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2017
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor ImmunityMaher G Nawaf, Maria H Ulvmar, David R Withers, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
The Journal of Experimental Medicine|February 17, 2010
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A Quezada, Tyler R Simpson, Karl S Peggs, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Cancer Research|August 5, 2008
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stageR Houston Thompson, Xingxing Zang, Christine M Lohse, et al.
Pageof 65

Showing results (521-530 of 647) with videos related to

Sort By:
Pageof 65
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|July 10, 2009
Readiness to change as a mediator of the effect of a brief motivational intervention on posttreatment alcohol-related consequences of injured emergency department hazardous drinkersL A R Stein, P Allison Minugh, Richard Longabaugh, et al.
Immunity|March 31, 2019
Negative Co-stimulation Constrains T Cell Differentiation by Imposing Boundaries on Possible Cell StatesSpencer C Wei, Roshan Sharma, Nana-Ama A S Anang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 14, 2012
B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cellsJun Sik Lee, Lisa Scandiuzzi, Anjana Ray, et al.
Alcoholism, Clinical and Experimental Research|October 27, 2007
Treatment completion in a brief motivational intervention in the emergency department: the effect of multiple interventions and therapists' behaviorJanette Baird, Richard Longabaugh, Christina S Lee, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicitiesSalahaldin A Tahir, Jianjun Gao, Yuji Miura, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 25, 2017
Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor ImmunityMaher G Nawaf, Maria H Ulvmar, David R Withers, et al.
The Journal of Experimental Medicine|August 22, 2001
Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapyA van Elsas, R P Sutmuller, A A Hurwitz, et al.
The Journal of Experimental Medicine|February 17, 2010
Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hostsSergio A Quezada, Tyler R Simpson, Karl S Peggs, et al.
Cancer|February 10, 2010
Single-institution experience with ipilimumab in advanced melanoma patients in the compassionate use setting: lymphocyte count after 2 doses correlates with survivalGeoffrey Y Ku, Jianda Yuan, David B Page, et al.
Cancer Research|August 5, 2008
Serum-soluble B7x is elevated in renal cell carcinoma patients and is associated with advanced stageR Houston Thompson, Xingxing Zang, Christine M Lohse, et al.
Pageof 65